Back to search

Peptide record

TPDB22268

Antibacterial Hemolysis Toxicity standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22268
Antibacterial Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia PD_Hemolysis
standard
No
A 10-aa standard natural multi-activity (Antibacterial, Hemolysis, and Toxicity) peptide sequence curated from Peptipedia and PD_Hemolysis, with an available 3D structural model.
Sequence
KRIWQRIKDF
Physicochemical Analysis
C65H104N20O14
ANCEGHLMPSTYV
RIK
1389.67
11.47
4
1
4
+3
1.81
-1.290
78.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
395.78
1
Residue Composition
number
0
A
2
R
0
N
1
D
0
C
0
E
1
Q
0
G
0
H
2
I
0
L
2
K
0
M
1
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 1 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 2 L: 0 K: 2 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
10
C65H104N20O14
1389.67
11.47
+3
1.81
-1.290
Evidence Records 7 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
<25 µM
Hemolytic Cytotoxic
50% Hemolysis | <25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
50% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
250 µM
Hemolytic Cytotoxic
50% Hemolysis | 250 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 4 Activity

Activity

5% Killing
Toxicity
50 µM
Cytotoxic
5% Killing | 50 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 5 Activity

Activity

25% Killing
Toxicity
100 µM
Cytotoxic
25% Killing | 100 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 6 Activity

Activity

50% Hemolysis
Toxicity
>200 µM
Hemolytic Cytotoxic
50% Hemolysis | >200 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. | ACS Infect Dis | 2021
Evidence 7 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis